Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT05227209 |
| Consolidated Lead Sponsor | Sumitomo Pharma America |
| Therapeutic Condition Cohort | Neurology, Psychiatry, and Pain |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 64 participants (ACTUAL) |
| Registered Start Date | 2022-03-17 |
| WhyStopped Classification | Insufficient / Slow Accrual |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Advanced Research Center, Inc. | Anaheim, CA | Open Hospital Dossier -> |
| Clinical Neuroscience Solutions, Inc. | Jacksonville, FL | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Sumitomo Pharma America across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.